<p>Journey Medical Corporation（纳斯达克代码：DERM - 免费报告）- B. Riley 的分析师在 11 月 13 日星期四发布的报告中上调了 Journey Medical 的 2029 财年每股收益（EPS）预期。B. Riley 分析师 M. Mamtani 现在预计该公司将发布每股收益 0.93 美元，高于之前的 0.85 美元预期。市场普遍预计 Journey Medical 当前全年的每股收益为（1.02 美元）。</p>
<p>其他一些研究公司也对 DERM 发表了评论。Zacks Research 在 10 月 13 日星期一的研究报告中将 Journey Medical 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Journey Medical 股票的 “卖出（d-）” 评级。Lake Street Capital 在 8 月 13 日星期三的研究报告中将 Journey Medical 的目标价从 9.00 美元上调至 13.00 美元，并给予该公司 “买入” 评级。最后，HC Wainwright 在 8 月 25 日星期一的报告中开始覆盖 Journey Medical 的股票。他们对该股票给予了 “买入” 评级，并设定了 13.00 美元的目标价。三位分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，平均目标价为 12.17 美元。</p>
<p>获取 <strong>Journey Medical</strong> 的提醒：</p>
<p><strong>查看我们关于 Journey Medical 的最新股票报告</strong></p>
<h2>Journey Medical 股票下跌 2.7%</h2>
<p>Journey Medical 的股票在周五的午盘交易中下跌 0.21 美元，达到 7.48 美元。该公司 143,313 股股票成交，较其平均成交量 124,969 股有所增加。该公司的市值为 1.9683 亿美元，市盈率为-21.47，贝塔值为 0.80。Journey Medical 的 52 周低点为 3.54 美元，52 周高点为 9.40 美元。该公司的 50 日简单移动平均线为 7.63 美元，200 日简单移动平均线为 7.32 美元。该公司的债务与股本比率为 1.11，速动比率为 0.95，流动比率为 1.27。</p>
<p>Journey Medical（纳斯达克代码：DERM - 获取免费报告）最近在 11 月 12 日星期三发布了季度财报。该公司报告本季度每股收益为（0.09 美元），低于分析师共识预期的（0.08 美元）0.01 美元。Journey Medical 的股本回报率为-42.71%，净利润率为-14.58%。该公司本季度的收入为 1763 万美元，而分析师预期为 1885 万美元。</p>
<h2>机构资金流入和流出</h2>
<p>机构投资者最近对该股票的持仓进行了调整。新泽西州警察和消防员退休系统在第二季度购买了 Journey Medical 的新头寸，价值约 29,000 美元。美国银行在第二季度将其在 Journey Medical 的股份增加了 4,707.0%。美国银行目前拥有 4,134 股该公司的股票，价值 30,000 美元，此前在该期间内又收购了 4,048 股。Raymond James Financial Inc.在第二季度收购了 Journey Medical 的新头寸，价值约 36,000 美元。摩根大通在第二季度购买了 Journey Medical 的新股份，价值 41,000 美元。最后，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度收购了 Journey Medical 的新股份，价值 48,000 美元。机构投资者和对冲基金持有该公司 7.25% 的股份。</p>
<h2>Journey Medical 公司简介</h2>
<p>（获取免费报告）</p>
<p>Journey Medical Corporation 专注于开发和商业化用于治疗美国皮肤病的药品。该公司的市场产品包括 Qbrexza，一种用于治疗原发性腋下多汗症的药用湿巾；Accutane，一种口服异维 A 酸药物，用于治疗严重的顽固性结节性痤疮；以及 Amzeeq，一种用于治疗中度至重度痤疮炎性病变的米诺环素外用制剂。</p>
<h2>了解更多</h2>
<ul>
<li>五只我们更看好的股票，胜过 Journey Medical</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>艾利 Lilly 与特朗普达成协议：为什么自那以来股价上涨了 10%</li>
<li>如何投资保险公司：指南</li>
<li>我们从 AST SpaceMobile 的第三季度财报中学到了什么</li>
<li>三只值得购买和持有的医疗保健分红股票</li>
<li>三只在每个人追逐 NVIDIA 时悄然利用 AI 的股票</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Journey Medical 吗？</h2>
<p>在你考虑 Journey Medical 之前，你需要听听这个。</p>
<p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Journey Medical 并不在名单上。</p>
<p>虽然 Journey Medical 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

DERM

<p>B. Riley 分析师将 Journey Medical 的 2029 财年每股收益预期从 0.85 美元上调至 0.93 美元。该股票的共识评级为 “持有”，平均目标价为 12.17 美元。Journey Medical 的股票目前交易价格为 7.48 美元，下跌 2.7%。该公司报告第三季度每股亏损 0.09 美元，低于预期 0.01 美元。机构投资者正在调整他们在该股票上的持仓</p>

<p>Journey Medical Corporation (NASDAQ:DERM - Free Report) - Analysts at B. Riley raised their FY2029 earnings per share (EPS) estimates for Journey Medical in a report issued on Thursday, November 13th. B. Riley analyst M. Mamtani now expects that the company will post earnings of $0.93 per share for the year, up from their previous estimate of $0.85. The consensus estimate for Journey Medical's current full-year earnings is ($1.02) per share.</p>
<div class="lb-trans"><p>Journey Medical Corporation（纳斯达克代码：DERM - 免费报告）- B. Riley 的分析师在 11 月 13 日星期四发布的报告中上调了 Journey Medical 的 2029 财年每股收益（EPS）预期。B. Riley 分析师 M. Mamtani 现在预计该公司将发布每股收益 0.93 美元，高于之前的 0.85 美元预期。市场普遍预计 Journey Medical 当前全年的每股收益为（1.02 美元）。</p>
</div><p>A number of other research firms have also commented on DERM. Zacks Research raised shares of Journey Medical from a &#34;strong sell&#34; rating to a &#34;hold&#34; rating in a research report on Monday, October 13th. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Journey Medical in a research report on Wednesday, October 8th. Lake Street Capital increased their target price on shares of Journey Medical from $9.00 to $13.00 and gave the company a &#34;buy&#34; rating in a research note on Wednesday, August 13th. Finally, HC Wainwright assumed coverage on shares of Journey Medical in a report on Monday, August 25th. They issued a &#34;buy&#34; rating and a $13.00 price target on the stock. Three analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of &#34;Hold&#34; and an average price target of $12.17.</p>
<div class="lb-trans"><p>其他一些研究公司也对 DERM 发表了评论。Zacks Research 在 10 月 13 日星期一的研究报告中将 Journey Medical 的股票评级从 “强烈卖出” 上调至 “持有”。Weiss Ratings 在 10 月 8 日星期三的研究报告中重申了对 Journey Medical 股票的 “卖出（d-）” 评级。Lake Street Capital 在 8 月 13 日星期三的研究报告中将 Journey Medical 的目标价从 9.00 美元上调至 13.00 美元，并给予该公司 “买入” 评级。最后，HC Wainwright 在 8 月 25 日星期一的报告中开始覆盖 Journey Medical 的股票。他们对该股票给予了 “买入” 评级，并设定了 13.00 美元的目标价。三位分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat.com 的数据，该公司目前的共识评级为 “持有”，平均目标价为 12.17 美元。</p>
</div><p>Get <strong>Journey Medical</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Journey Medical</strong> 的提醒：</p>
</div><p><strong>View Our Latest Stock Report on Journey Medical</strong></p>
<div class="lb-trans"><p><strong>查看我们关于 Journey Medical 的最新股票报告</strong></p>
</div><h2>Journey Medical Stock Down 2.7%</h2>
<div class="lb-trans"><h2>Journey Medical 股票下跌 2.7%</h2>
</div><p>Shares of Journey Medical stock traded down $0.21 during midday trading on Friday, reaching $7.48. 143,313 shares of the company's stock traded hands, compared to its average volume of 124,969. The company has a market cap of $196.83 million, a price-to-earnings ratio of -21.47 and a beta of 0.80. Journey Medical has a 52 week low of $3.54 and a 52 week high of $9.40. The company's 50 day simple moving average is $7.63 and its 200 day simple moving average is $7.32. The company has a debt-to-equity ratio of 1.11, a quick ratio of 0.95 and a current ratio of 1.27.</p>
<div class="lb-trans"><p>Journey Medical 的股票在周五的午盘交易中下跌 0.21 美元，达到 7.48 美元。该公司 143,313 股股票成交，较其平均成交量 124,969 股有所增加。该公司的市值为 1.9683 亿美元，市盈率为-21.47，贝塔值为 0.80。Journey Medical 的 52 周低点为 3.54 美元，52 周高点为 9.40 美元。该公司的 50 日简单移动平均线为 7.63 美元，200 日简单移动平均线为 7.32 美元。该公司的债务与股本比率为 1.11，速动比率为 0.95，流动比率为 1.27。</p>
</div><p>Journey Medical (NASDAQ:DERM - Get Free Report) last posted its quarterly earnings results on Wednesday, November 12th. The company reported ($0.09) earnings per share for the quarter, missing analysts' consensus estimates of ($0.08) by ($0.01). Journey Medical had a negative return on equity of 42.71% and a negative net margin of 14.58%.The company had revenue of $17.63 million during the quarter, compared to analyst estimates of $18.85 million.</p>
<div class="lb-trans"><p>Journey Medical（纳斯达克代码：DERM - 获取免费报告）最近在 11 月 12 日星期三发布了季度财报。该公司报告本季度每股收益为（0.09 美元），低于分析师共识预期的（0.08 美元）0.01 美元。Journey Medical 的股本回报率为-42.71%，净利润率为-14.58%。该公司本季度的收入为 1763 万美元，而分析师预期为 1885 万美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><p>Institutional investors have recently made changes to their positions in the stock. Police &amp; Firemen s Retirement System of New Jersey bought a new position in Journey Medical during the second quarter worth about $29,000. Bank of America Corp DE boosted its stake in shares of Journey Medical by 4,707.0% during the 2nd quarter. Bank of America Corp DE now owns 4,134 shares of the company's stock worth $30,000 after acquiring an additional 4,048 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Journey Medical during the 2nd quarter worth approximately $36,000. JPMorgan Chase &amp; Co. bought a new stake in Journey Medical in the 2nd quarter valued at $41,000. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in Journey Medical during the 2nd quarter valued at $48,000. Institutional investors and hedge funds own 7.25% of the company's stock.</p>
<div class="lb-trans"><p>机构投资者最近对该股票的持仓进行了调整。新泽西州警察和消防员退休系统在第二季度购买了 Journey Medical 的新头寸，价值约 29,000 美元。美国银行在第二季度将其在 Journey Medical 的股份增加了 4,707.0%。美国银行目前拥有 4,134 股该公司的股票，价值 30,000 美元，此前在该期间内又收购了 4,048 股。Raymond James Financial Inc.在第二季度收购了 Journey Medical 的新头寸，价值约 36,000 美元。摩根大通在第二季度购买了 Journey Medical 的新股份，价值 41,000 美元。最后，MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.在第二季度收购了 Journey Medical 的新股份，价值 48,000 美元。机构投资者和对冲基金持有该公司 7.25% 的股份。</p>
</div><h2>Journey Medical Company Profile</h2>
<div class="lb-trans"><h2>Journey Medical 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris.</p>
<div class="lb-trans"><p>Journey Medical Corporation 专注于开发和商业化用于治疗美国皮肤病的药品。该公司的市场产品包括 Qbrexza，一种用于治疗原发性腋下多汗症的药用湿巾；Accutane，一种口服异维 A 酸药物，用于治疗严重的顽固性结节性痤疮；以及 Amzeeq，一种用于治疗中度至重度痤疮炎性病变的米诺环素外用制剂。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Journey Medical</li>
<li>How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?</li>
<li>Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since</li>
<li>How to Invest in Insurance Companies: A Guide</li>
<li>Here's What We Learned From AST SpaceMobile's Q3 Earnings Report</li>
<li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li>
<li>3 Stocks Quietly Leveraging AI While Everyone Chases NVIDIA</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Journey Medical</li>
<li>零售投资者如何交易多伦多证券交易所（TSX）？</li>
<li>艾利 Lilly 与特朗普达成协议：为什么自那以来股价上涨了 10%</li>
<li>如何投资保险公司：指南</li>
<li>我们从 AST SpaceMobile 的第三季度财报中学到了什么</li>
<li>三只值得购买和持有的医疗保健分红股票</li>
<li>三只在每个人追逐 NVIDIA 时悄然利用 AI 的股票</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9REVSTQ" alt="" original-src="https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx?Prefix=NASDAQ&amp;Symbol=DERM"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Journey Medical Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Journey Medical 吗？</h2>
</div><p>Before you consider Journey Medical, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Journey Medical 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Journey Medical wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 跟踪华尔街顶级评级和表现最佳的研究分析师及其每日推荐的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买...而 Journey Medical 并不在名单上。</p>
</div><p>While Journey Medical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Journey Medical 目前在分析师中获得了持有评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

B. Riley 上调了 Journey Medical 的盈利预测